Form D · Pharmaceuticals
Savara Inc
Austin, TX · CIK 0001160308
Offering snapshot reported Jan 2, 2020 · SEC filing
- Reported sold
- $26.8M Offering amount: $75M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 24, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 2, 2020 | Initial | $26,779,912 | No comparison | 18 | SEC filing |
| Mar 5, 2014 | Initial | $4,162,089 | No comparison | 2 | SEC filing |
| Aug 11, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.41M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-356981
$48,220,050 of the Total Offering Amount has not been received by the Issuer to date and will not be received until such time, if any, that the Warrants authorized under this offering are exercised.
Up to an additional $2,531,553 may be paid if and when investors exercise the warrants issued under this offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | 2347 | |
| Evercore Group L.L.C. | 42405 |
Source: Form D, filed Jan 2, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Badrul Chowdhury | Executive |
| Mike Ciesla | Executive |
| Brian M. Culley | Director, Executive |
| Nevan Elam | Director |
| R. Martin Emanuele | Executive |
| Peter Ginsburg | Executive |
| Gregory D. Gorgas | Executive |
| Richard J. Hawkins | Director |
| Taneli Jouhikainen | Executive |
| Patrick L. Keran | Executive |
| Jack Lief | Director |
| John Lord | Executive |
| David L. Lowrance | Executive |
| Kate Mc Cabe | Executive |
| Joseph S. Mc Cracken | Director |
| Robert Neville | Director, Executive |
| Matthew Pauls | Director |
| David A. Ramsay | Director |
| Brandi L. Roberts | Executive |
| Lewis Shuster | Director |
| Ricky Sun | Director |
| An Van Es Johansson | Director |
| Santosh J. Vetticaden | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6836 Bee Cave Road Building Iii, Suite 200
Austin, TX, 78746
Austin, TX, 78746